AlzeCure presented new preclinical data on its Ne
Author: Michael
Totus Medicines presented Phase 1a clinical data
Aspen Neuroscience presented 12-month safety, tol
Researchers pinpoint the exact neurons hit harde
Early recognition for Behcet’s disease undersc
German biotech launches the first CE-certified P
ImmunoBrain presented Phase 1b results for IBC-Ab
Showing at AD/PD 2026 signals blood-based Alzhei
Origami Therapeutics CEO on harnessing autophagy
New biotech R1 Therapeutics emerges with fresh b